Merrimack Pharmaceuticals (NASDAQ: MACK)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Merrimack Pharmaceuticals (NASDAQ: MACK) through any online brokerage.
The latest price target for Merrimack Pharmaceuticals (NASDAQ: MACK) was reported by Baird on Monday, October 22, 2018. The analyst firm set a price target for 4.00 expecting MACK to fall to within 12 months (a possible -30.31% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Merrimack Pharmaceuticals (NASDAQ: MACK) is $5.74 last updated Today at June 27, 2022, 5:56 PM UTC.
A quarterly cash dividend of $0.50 per share of Class A Common Stock. The quarterly cash dividend was payable on December 23, 2019 to stockholders of record on December 13, 2019.
Merrimack Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Merrimack Pharmaceuticals.
Merrimack Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.